Rosetta Omics

Solution

INTERVIEWS

Interview with our CEO: The Future of Precision Oncology

We’re excited to share this thought-provoking conversation between Dr. Wahid Awad, Ph.D. MBA, CEO of Rosetta Omics and Dr. Muhammad Younis on the future of cancer care.
In this interview, Dr. Awad dives into:
🔹 The limitations of standard cancer treatments
🔹 The transformative power of AI, multiomics, and spatial biology
🔹 How Rosetta Omics is building predictive models that enhance patient outcomes and lower healthcare costs
He also explores the real-world challenges of clinical adoption and how we’re working to overcome them.

📖 Read the full interview here:
https://lnkd.in/eN3U3TmT

We are excited to share an exclusive conversation with Dr. Wahid Awad, Ph.D., MBA, CEO and Founder of Rosetta Omics—an award-winning healthcare deeptech startup dedicated to transforming cancer care.

In this thought-provoking interview, Dr. Awad opens up about his personal journey from academia to entrepreneurship, and how the loss of his father to cancer inspired him to dedicate his career to advancing precision medicine.

He highlights:

🔹 The limitations of current cancer treatments and why precision oncology is urgently needed

🔹 The transformative potential of AI, spatial multiomics, and advanced biomarker discovery

🔹 How Rosetta Omics is building predictive models to improve patient outcomes and reduce healthcare costs

🔹 The real-world challenges of clinical adoption—from physician education to reimbursement—and how the team is working to overcome them

Dr. Awad also shares Rosetta Omics’ upcoming milestones, including fundraising progress and the launch of the company’s second proof-of-concept study.

💡 His closing words resonate with the spirit of Rosetta Omics:

“You only fail when you give up.”

📖 Read the full interview here → https://sejelas.com/wahid-awad/

 

We are proud to share that our CEO & Founder, Dr. Wahid Awad, Ph.D., MBA, was recently featured in an interview with ActusPaysBas.

In this conversation (available in French 🇫🇷), Dr. Awad reflects on his 16-year relationship with the Netherlands, which began in 2008, and the role it has played in shaping his personal and professional journey. He also emphasizes the importance of fostering stronger collaboration between the French and Dutch private and public sectors—a vision that resonates deeply with Rosetta Omics’ mission of building global partnerships to advance precision oncology.

The Netherlands has long been a leader in life sciences, biotech, and translational research, and strengthening these international connections is key to accelerating innovation for cancer patients worldwide.

📖 Read the full interview here → https://lnkd.in/eev8mcAN

We thank Freek Wolter and Bertus Bouwman for this opportunity, and we look forward to continuing to strengthen international ties that support research, innovation, and the fight against cancer.

Rosetta Omics Kevin Adam, PhD, MBE Maastricht University Wageningen University & Research Berta Cillero Pastor

Paris Saclay Cancer Cluster (PSCC) France Biotech Medicen Paris Region Agoranov Bpifrance European Commission APICES CRO 4TU.Federation Joannette Polo @Embassy of the Kingdom of the Netherlands in France Denise Spiekerman van Weezelenburg

We are excited to share a recent video interview with our CEO & Founder, Dr. Wahid Awad, Ph.D., MBA, on the Life Science Success podcast.

In this inspiring conversation, Dr. Awad dives into:

🔹 How AI and spatial multiomics are reshaping the future of cancer care

🔹 His personal journey from academia to entrepreneurship, and how his father’s cancer diagnosis motivated the creation of Rosetta Omics

🔹 The challenges and opportunities of bringing precision oncology solutions to patients worldwide

🔹 Why international collaboration is key to scaling innovation in healthcare

At Rosetta Omics, we believe in pushing the boundaries of science to deliver meaningful impact for patients. This interview shines a light on both the vision and the passion driving our mission to revolutionize precision medicine.

📺 Watch the full interview here → Unlocking Cancer’s Secrets: AI & Multiomics with Rosetta Omics CEO

We are delighted to share that our CEO & Founder, Dr. Wahid Awad, Ph.D., MBA, recently spoke at a webinar dedicated to advancing cancer diagnostics and drug development.

In his presentation, Dr. Awad highlighted how Rosetta Omics integrates seamlessly into the standard clinical procedure of biopsy collection to provide oncologists with actionable insights that assist in treatment decision-making.

He also emphasized how our platform goes beyond diagnostics to:

🔹 Identify biomarkers of clinical interest

🔹 Support the discovery of new drug targets

🔹 Accelerate innovation in precision oncology

This session underscored Rosetta Omics’ mission to transform cancer care through the power of spatial multiomics and AI-driven biomarker discovery.

📺 Watch the replay here → https://www.linkedin.com/events/usingmulti-omics-aitoenhancepre7269426707999199232/theater/